Related topics

Sinovac: Q4 Earnings Snapshot

April 22, 2021 GMT

BEIJING (AP) _ Sinovac Biotech Ltd. (SVA) on Thursday reported fourth-quarter profit of $108.8 million.

The Beijing-based company said it had profit of 96 cents per share. Earnings, adjusted for non-recurring costs, were $1.02 per share.

The biopharmaceutical company posted revenue of $327.5 million in the period.

For the year, the company reported profit of $110.4 million, or 97 cents per share. Revenue was reported as $510.6 million.

Sinovac shares have declined almost 7% since the beginning of the year. In the final minutes of trading on Thursday, shares hit $6.47, a drop of 21% in the last 12 months.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on SVA at https://www.zacks.com/ap/SVA